These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3982241)

  • 1. Discrimination between organic and hepatic encephalopathy by means of continuous reaction times.
    Elsass P; Christensen SE; Mortensen EL; Vilstrup H
    Liver; 1985 Feb; 5(1):29-34. PubMed ID: 3982241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Number connection test and continuous reaction times in assessment of organic and metabolic encephalopathy: a comparative study.
    Elsass P; Christensen SE; Jørgensen F; Mortensen EL; Vilstrup H
    Acta Pharmacol Toxicol (Copenh); 1984 Feb; 54(2):115-9. PubMed ID: 6711318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimal hepatic encephalopathy characterized by parallel use of the continuous reaction time and portosystemic encephalopathy tests.
    Lauridsen MM; Schaffalitzky de Muckadell OB; Vilstrup H
    Metab Brain Dis; 2015 Oct; 30(5):1187-92. PubMed ID: 26016624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reaction time and brain disease: relations to location, etiology and progression of cerebral dysfunction.
    Elsass P; Hartelius H
    Acta Neurol Scand; 1985 Jan; 71(1):11-9. PubMed ID: 3976348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Concentration problems, delayed reaction. "Diagnosis at a glance" points to hepatic encephalopathy].
    MMW Fortschr Med; 2003 Jun; 145(25):55. PubMed ID: 12891858
    [No Abstract]   [Full Text] [Related]  

  • 6. Qualifying and quantifying minimal hepatic encephalopathy.
    Morgan MY; Amodio P; Cook NA; Jackson CD; Kircheis G; Lauridsen MM; Montagnese S; Schiff S; Weissenborn K
    Metab Brain Dis; 2016 Dec; 31(6):1217-1229. PubMed ID: 26412229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychiatric sequelae of portal-systemic encephalopathy: a review.
    Tarter RE; Hegedus AM; Van Thiel DH
    Int J Neurosci; 1984 Nov; 24(3-4):203-16. PubMed ID: 6511210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender and age effects on the continuous reaction times method in volunteers and patients with cirrhosis.
    Lauridsen MM; Grønbæk H; Næser EB; Leth ST; Vilstrup H
    Metab Brain Dis; 2012 Dec; 27(4):559-65. PubMed ID: 22614824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The continuous reaction times method for diagnosing, grading, and monitoring minimal/covert hepatic encephalopathy.
    Lauridsen MM; Thiele M; Kimer N; Vilstrup H
    Metab Brain Dis; 2013 Jun; 28(2):231-4. PubMed ID: 23299303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous reaction time in patients with hepatic encephalopathy. A quantitative measure of changes in consciousness.
    Elsass P; Christensen SE; Ranek L; Theilgaard A; Tygstrup N
    Scand J Gastroenterol; 1981 Apr; 16(3):441-7. PubMed ID: 16435490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis and prevalence of latent hepatic encephalopathy].
    Koch H; Schauder P; Schäfer G; Dahme B; Ebel W; Vahldiek B; König F; Henning H
    Z Gastroenterol; 1990 Nov; 28(11):610-5. PubMed ID: 2288139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of common chronic medical conditions on psychometric tests used to diagnose minimal hepatic encephalopathy.
    Lauridsen MM; Poulsen L; Rasmussen CK; Høgild M; Nielsen MK; de Muckadell OB; Vilstrup H
    Metab Brain Dis; 2016 Apr; 31(2):267-72. PubMed ID: 26435407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simple tools for complex syndromes: a three-level difficulty test for hepatic encephalopathy.
    Montagnese S; Schiff S; Turco M; Bonato CA; Ridola L; Gatta A; Nousbaum JB; Riggio O; Merkel C; Amodio P
    Dig Liver Dis; 2012 Nov; 44(11):957-60. PubMed ID: 22819289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the simplified Animal Naming Test as primary screening tool for the diagnosis of covert hepatic encephalopathy.
    Labenz C; Beul L; Toenges G; Schattenberg JM; Nagel M; Sprinzl MF; Nguyen-Tat M; Zimmermann T; Huber Y; Marquardt JU; Galle PR; Wörns MA
    Eur J Intern Med; 2019 Feb; 60():96-100. PubMed ID: 30131209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ambulatory diagnosis and therapy control of portasystemic encephalopathy in patients with liver cirrhosis].
    Rink C; Mantel E; Haerting J; Nilius R
    Dtsch Z Verdau Stoffwechselkr; 1985; 45(6):295-301. PubMed ID: 4092654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychomotor dysfunctions in alcoholic and post-necrotic cirrhotic patients without overt encephalopathy.
    Puca FM; Antonaci F; Panella C; Guglielmi FW; Barone M; Francavilla A; Cerutti R
    Acta Neurol Scand; 1989 Apr; 79(4):280-7. PubMed ID: 2728850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis of hepatic coma].
    Mörl M
    Dtsch Med Wochenschr; 1984 Mar; 109(13):501-3. PubMed ID: 6705700
    [No Abstract]   [Full Text] [Related]  

  • 18. Usefulness of magnetic resonance spectroscopy for diagnosis of hepatic encephalopathy in a patient with relapsing confusional syndrome.
    Cordoba J; Hinojosa C; Sampedro F; Alonso J; Rovira A; Quiroga S; Esteban R; Guardia J
    Dig Dis Sci; 2001 Nov; 46(11):2451-5. PubMed ID: 11713951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent developments in the diagnosis and treatment of covert/minimal hepatic encephalopathy.
    De Rui M; Montagnese S; Amodio P
    Expert Rev Gastroenterol Hepatol; 2016; 10(4):443-50. PubMed ID: 26758861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary metabolic profiling by
    McPhail MJ; Montagnese S; Villanova M; El Hadi H; Amodio P; Crossey MM; Williams R; Cox IJ; Taylor-Robinson SD
    Metab Brain Dis; 2017 Apr; 32(2):331-341. PubMed ID: 27638475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.